Royce & Associates LP Utah Medical Products Inc Transaction History

Royce & Associates LP

$10.5 Billion
Q3 2024

A detailed history of Royce & Associates LP transactions in Utah Medical Products Inc stock. As of the latest transaction made, Royce & Associates LP holds 16,203 shares of UTMD stock, worth $986,924. This represents 0.01% of its overall portfolio holdings.

Number of Shares

16,203

Previous 16,203 -0.0%

Holding current value

$986,924

Previous $1.08 Million 0.18%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$68.14 - $84.23 $24,121 - $29,817	354 Added 2.23%	16,203 $1.15 Million
Q4 2023 Feb 12, 2024	SELL	$77.07 - $87.05 $1.3 Million - $1.47 Million	-16,867 Reduced 51.56%	15,849 $1.33 Million
Q3 2023 Nov 09, 2023	BUY	$83.86 - $99.16 $4,109 - $4,858	49 Added 0.15%	32,716 $2.81 Million
Q2 2023 Aug 07, 2023	BUY	$87.76 - $99.95 $702 - $799	8 Added 0.02%	32,667 $3.04 Million
Q1 2023 May 04, 2023	BUY	$87.14 - $100.3 $234,929 - $270,408	2,696 Added 9.0%	32,659 $3.1 Million
Q4 2022 May 23, 2023	SELL	$82.45 - $101.88 $222,285 - $274,668	-2,696 Reduced 8.25%	29,963 $3.01 Million
Q4 2022 Feb 13, 2023	SELL	$82.45 - $101.88 $166,301 - $205,491	-2,017 Reduced 6.31%	29,963 $3.01 Million
Q3 2022 Nov 03, 2022	BUY	$80.73 - $95.26 $5,974 - $7,049	74 Added 0.23%	31,980 $2.73 Million
Q2 2022 Aug 04, 2022	BUY	$81.49 - $90.28 $3,911 - $4,333	48 Added 0.15%	31,906 $2.74 Million
Q1 2022 May 05, 2022	BUY	$86.04 - $99.89 $6,366 - $7,391	74 Added 0.23%	31,858 $2.86 Million
Q4 2021 Feb 07, 2022	SELL	$88.84 - $124.71 $444 - $623	-5 Reduced 0.02%	31,784 $3.18 Million
Q3 2021 Nov 10, 2021	SELL	$84.89 - $97.16 $4,329 - $4,955	-51 Reduced 0.16%	31,789 $2.95 Million
Q2 2021 Aug 06, 2021	SELL	$82.4 - $89.39 $412 - $446	-5 Reduced 0.02%	31,840 $2.71 Million
Q1 2021 May 10, 2021	BUY	$83.74 - $92.99 $11,472 - $12,739	137 Added 0.43%	31,845 $2.76 Million
Q4 2020 Feb 08, 2021	SELL	$79.35 - $94.4 $130,530 - $155,288	-1,645 Reduced 4.93%	31,708 $2.67 Million
Q3 2020 Nov 12, 2020	BUY	$78.22 - $92.62 $4,302 - $5,094	55 Added 0.17%	33,353 $2.66 Million
Q2 2020 Aug 07, 2020	BUY	$78.0 - $106.28 $234 - $318	3 Added 0.01%	33,298 $2.95 Million
Q1 2020 May 12, 2020	BUY	$77.05 - $108.52 $693 - $976	9 Added 0.03%	33,295 $3.13 Million
Q4 2019 Feb 06, 2020	SELL	$91.85 - $109.3 $2,939 - $3,497	-32 Reduced 0.1%	33,286 $3.59 Million
Q3 2019 Nov 13, 2019	BUY	$83.55 - $100.0 $5,932 - $7,100	71 Added 0.21%	33,318 $3.19 Million
Q2 2019 Aug 12, 2019	BUY	$77.76 - $95.7 $155 - $191	2 Added 0.01%	33,247 $3.18 Million
Q1 2019 May 09, 2019	BUY	$80.49 - $99.2 $4,748 - $5,852	59 Added 0.18%	33,245 $2.93 Million
Q4 2018 Feb 11, 2019	SELL	$74.64 - $97.62 $1,343 - $1,757	-18 Reduced 0.05%	33,186 $2.76 Million
Q3 2018 Nov 13, 2018	SELL	$86.0 - $114.75 $78,002 - $104,078	-907 Reduced 2.66%	33,204 $3.13 Million
Q2 2018 Aug 09, 2018	BUY	$95.3 - $116.0 $3,621 - $4,408	38 Added 0.11%	34,111 $3.76 Million
Q1 2018 May 14, 2018	SELL	$79.3 - $99.1 $1,189 - $1,486	-15 Reduced 0.04%	34,073 $3.37 Million
Q4 2017 Feb 09, 2018	BUY	$74.4 - $84.05 $74 - $84	1 Added 0.0%	34,088 $2.78 Million
Q3 2017 Nov 13, 2017	SELL	$68.55 - $74.65 $144,846 - $157,735	-2,113 Reduced 5.84%	34,087 $2.51 Million
Q2 2017 Aug 07, 2017	BUY	N/A	36,200	36,200 $2.62 Million

Others Institutions Holding UTMD

# of Institutions

108

Shares Held

2.11M

Call Options Held

Put Options Held

View Full List

About UTAH MEDICAL PRODUCTS INC

Ticker UTMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 3,625,200
Market Cap $221M
Description
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO u...

More about UTMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account

Royce & Associates LP Utah Medical Products Inc Transaction History